Skip to main content
. 2014 Mar 22;18(4):372–378. doi: 10.1016/j.bjid.2013.11.008

Table 1.

Demographic, clinical and ART characteristics for 214 pregnant women included in this study from HGNI and HFSE, Rio de Janeiro, Brazil.

Variable ARTexp women (n = 36, 16.8%) ARTn women (n = 178, 83.2%)
Age (years), Median (IQR) 30.7 (26.8–34.8) 27.6 (23.3–31.9)



Race, n (%)
 White 16 (44.4) 58 (32.5)
 Non-white 20 (55.6) 113 (63.5)
 Not declared 7 (4.0)



Previous pregnancies, n (%)
 1–2 16 (44.4) 91 (51.1)
 ≥3 12 (33.3) 62 (34.8)



Living children, n (%)a
 1–2 13 (36.1) 95 (53.4)
 >3 9 (25.0) 40 (22.5)



HIV exposure category, n (%)
 Sexual 31 (88.1) 166 (93.8)
 Intravenous drug use 0 (0.0) 2 (1.1)
 Unknown 5 (11.9) 10 (5.1)
 Previous AIDS-defining illness, n (%) 5 (13.9) 1 (0.6)
 Time until HIV diagnosis (months), median (IQR) 36 (21.2–55.5) 7.3 (1.2–19.3)



CD4 (cells/mm3) data
 Nadir ≥ 200 cells/μL, n (%) 22 (61.1) 159 (89.3)
 Baseline, median (IQR) 351.5 (193.8–466.0) 422.5 (297.8–569.8)
 Higher value during pregnancy, median (IQR) 446.0 (288.0–561.0) 520.0 (379.0–681.0)
 Lower value during pregnancy, median (IQR) 338.0 (190.5–342.9) 404.0 (292.0–551.0)



Viral load (copies/mL)
 Baseline, median (IQR) 400.0 (400.0–2900.0) 4950.0 (640.0–29000.0)
 Viral load > 1000 copies/mL during pregnancy, n (%) 10 (28.6) 28 (17.9)
 Gestational age on baseline, mean (±SE) 15.7 (1.0) 21.1 (0.6)



Route of delivery, n (%)
 Vaginal route 16 (44.4) 61 (34.3)
 Cesarean section 20 (55.6) 117 (65.7)



Pregnancy outcome, n (%)
 Term birth 30 (83.4) 163 (91.5)
 Preterm birth 4 (11.1) 14 (7.8)
 Abortion 2 (5.5) 1 (0.7)



ART-based regimen, n (%)
 NNRTI 16 (44.4) 73 (41.1)
 PI 19 (52.8) 103 (57.8)
 PI + NNRTI 1 (2.8)
 NRTI 2 (1.1)
 ART use during pregnancy (weeks), median (IQR) N/A 16.1 (10.0–22.0)
 ARV modification, n (%) 24 (66.7%) 10 (5.6)

aExcluding current pregnancy; IQR = interquartile range; SE = standard error.